{"product_id":"rinazina-doppia-azione-0-5-mg-ml-0-6-mg-ml-spary-nasale-10-ml-acquista-online-su-farmaclick","title":"Rinazina Doppia Azione 0.5 Mg \/ Ml + 0.6 Mg \/ Ml Spary Nasale 10 Ml | Acquista Online su Farmaclick","description":"\u003ch2\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eRinazina Doppia Azione 0,5 mg\/ml + 0,6 mg\/ml Spary Nasale 10 ml\u003c\/font\u003e\u003c\/font\u003e\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003ca href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_001136_039064_FI.pdf\u0026amp;retry=0\u0026amp;sys=m0b1l3\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eFOGLIETTO ILLUSTRATIVO AIFA\u003c\/font\u003e\u003c\/font\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003ca href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_001136_039064_FI.pdf\u0026amp;retry=0\u0026amp;sys=m0b1l3\"\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eDENOMINAZIONE:\u003c\/font\u003e\u003c\/font\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eRINAZINA DOPPIA AZIONE 0,5 MG\/ML + 0,6 MG\/ML SPRAY NASALE, SOLUZIONE\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eCATEGORIA FARMACOTERAPEUTICA: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eSimpaticomimetici, associazioni esclusi i corticosteroidi.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePRINCIPI ATTIVI: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eXilometazolina cloridrato e ipratropio bromuro.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eECCIPIENTI: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eDisodio edetato; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eglicerolo (85%); \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eacido cloridrico (per la correzione del pH); \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003esodio idrossido (per la correzione del pH); \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eacqua depurata.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eINDICAZIONI: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eTrattamento sintomatico della congestione nasale e della rinorrea asso ciate ai comuni raffreddori.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eCONTROINDICAZIONI\/EFF.SECONDAR: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIl medicinale non deve essere somministrato a bambini al di sotto dei 18 anni di eta' a causa della mancanza di sufficiente documentazione; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eipersensibilita' ai principi attivi o ad uno qualsiasi degli eccipient i elencati; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eipersensibilita' nota all'atropina oa sostanze similari, quali ad esempio iosciamina e scopolamina. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eDopo interventi chirurgici in cui la dura madre possa essere stata esposta: ipofisectomia transfe noidale o altri interventi per via transnasale. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIn pazienti con glauco ma; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ein pazienti con rinite secca.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePOSOLOGIA: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eAdulti: 1 nebulizzazione in ogni narice fino a 3 volte al giorno. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eDevo non trascorrere almeno 6 ore tra due dosi. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon superare le 3 applicazioni ni giornaliere in ciascuna narice. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLa durata del trattamento non deve superare i 7 giorni. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eSi raccomanda di interrompere il trattamento, quando i sintomi sono diminuiti, anche prima della durata massima del trattamento di 7 giorni, al fine di minimizzare il rischio di reazioni av versetto. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePopolazione pediatrica: l'uso del medicinale non e' raccomandato in bambini e adolescenti al di sotto dei 18 anni di eta' per mancanz a di sufficiente documentazione. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eAnziani: esiste solo una limitata esperienza d'uso in pazienti con un'eta' superiore ai 70 anni.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eModo di so mministrazione: prima dell'applicazione iniziale, premere la pompa azi onandola 4 volte. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eUna volta premuta, la pompa rimarra' car normalmente ica per tutto il periodo di trattamento giornaliero continuo. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eQualora si premesse completamente il beccuccio lo spray non dovesse uscire fuoriuscire, o se il prodotto non fosse utilizzato non e' stato per piu' di 6 giorni, la pompa a av' bisogno di essere ricaricata con le 4 pressioni eseguite all'i nizio.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eCONSERVAZIONE: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eQuesto medicinale non richiede alcuna condizione particolare di conservazione.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eAVVERTENZE: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIl prodotto medicinale deve essere somministrato con cautela nei pazienti affetti da: ipertensione, malattie cardiovascolari; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eipertiroidismo, diabe te mellito; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eipertrofia della prostata, stenosi ureterale; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003efeocromocito ma. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eSi raccomanda nei pazienti di cautela predisposti a: glaucoma ad ango lo chiuso; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eepistassi (es. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eanziani); \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eileo paralitico; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003efibrosi cistica. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePuo' verificarsi bro ipersensibilita' immediata, inclusi orticaria, angioe dema, edema faringeo e anafilassi. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIl prodotto med icinale deve essere usato con cautela in pazienti che sono sensibili a gli agenti adrenergici, che possono osare sintomi quali disturbi del so nno, vertigini, tremore, aritmie cardiache o ipertensione.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLa durata d'el trattamento non deve superare i 7 giorni, poiche' il trattamento cr onico con xilometazolina cloridrato puo' causare gonfiore della mucosa nasale e ipersecrezione alla maggiore sensibilita' cellulare, \"effetto rebound\" (rinite medicamentosa). \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eI pazienti devono essere è vero nell'evitare di spruzzare il farmaco attorno o negli occhi. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eSe il medicinale entra in contatto con gli occhi, si possono verificare le seguenti eventualita': visione sfuocata temporanea, irritazione, dol ore, occhi arrossati. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePuo' venire un aggravamento del glaucoma ad angolo chiuso.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eINTERAZIONI: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eGli Inibitori della Monoaminossidasi (Inibitori MAO): l'uso concomitan te o l'uso nelle ultime 2 settimane di preparazioni a base di simpatic omimetici puo' indurre ipertensione grave e pertanto non e' raccomandato. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePreparazioni a base di simpaticomimetici rilasciano catecolamine, e cio' porta ad un maggiore rilascio di noradrenalina che viceversa ha un effetto vasocostrittore portando ad un innalzamento della pressione nematica. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIn casi severi di ipertensione, il trattamento con il prod deve essere sospeso e si deve trattare l'ipertensione.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eGli antide pressivi tri- e tetra-ciclici: l'uso concomitante o l'uso nelle ultime 2 settimane di antidepressivi triciclici e di preparati a base di sim paticomimetici puo' portare ad un aumento dell'effetto simpaticomimeti co della xilometazolina e quindi non e 'raccomandato. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLa somministrazione concomitante di altri medicinali anticolinergici puo' aumentare l'effetto anticolinergico. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLe principi attivi del farmaco menzionate sopra sono state studiate individualmente per entrambi i principi attivi del farmaco, n on in combinazione. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon sono stati condotti studi formali di interazio ne con altre sostanze.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eEFFETTIDESIDERATI: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLe reazioni IN avverse piu' comunemente riportate sono epistassi avvenute nel 14,8 % dei pazienti e secchezza nasale nel 11,3% dei pazienti. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eMolti degli eventi avversi sono anche sintomi del comune raffr eddore. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLe seguenti reazioni avverse sono state riportate in due studi clinici randomizzati e in uno studio non interventistico con il prodo tto dopo l'immissione in commercio e durante la sorveglianza post-mark eting. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLe reazioni avverse sono classificate mediante la classificazione p er sistemi e organi e frequenza. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eLe frequenze sono definitive come: mo lto comune (\u0026gt;=1\/10), comune (\u0026gt;=1\/100, \u0026lt; 1\/10), non comune (\u0026gt;= 1\/1.000, \u0026lt; 1\/100), raro (\u0026gt;= 1\/10.000, \u0026lt; 1\/1.000), molto raro (\u0026lt; 1\/10.000), non nota.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon nota: ipersensibilita'. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eD isturbi psichiatrici. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon comune: insonnia. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatologia del sistema nervoso oso. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eComune: disgeusia, mal di testa; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon comune: parosmia, vertigini, tremore. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatologia dell'occhio. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon comune: irritazione oculare, secc hezza oculare; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon nota: disturbo dell'accomodazione, peggioramento de l glaucoma ad angolo chiuso, dolore oculare, fotopsia, aumento della p ressione intraoculare, visione offuscata, midriasi, aloni visivi. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatologia cardiaca. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon comune: palpitazioni, tachicardia; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon nota: fibr illazione atriale. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatologie respiratorie, toraciche e mediastiniche.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eMolto comune: epistassi, secchezza nasale; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ecomune: disagio nasale, con gestione nasale, secchezza delle fauci, irritazione della gola, rinalg ia; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon comune: ulcera nasale, starnuto, dolore orofaringeo, tosse, di sfonia; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eraro: rinorrea; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon nota: disagio ai seni paranasali, laringos pasmo, edema faringeo. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatologie gastrointestinali. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eComune: secchezza delle fauci; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon comune: dispepsia, nausea; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon nota: disfagia. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatolo gie della cute e del tessuto sottocutaneo. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon comune: prurito, eruzione cutanea, orticaria. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatologie renali e urinarie. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon nota memoria: urinaria. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003ePatologie sistemiche e condizioni relative alla sede di somministrazi one. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon comune: disagio, fatica; \u003c\/font\u003e\u003cfont style=\"vertical-align: inherit;\"\u003enon nota: disagio al torace, sete.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eL a segnalazione delle reazioni avverse sospette che si verifica dopo l'autorizzazione del medicinale e' importante, in quanto permette un m onitore continuo del rapporto beneficio\/rischio del medicinale.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eGRAVIDANZA E ALLATTAMENTO: \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon ci sono evidenze sufficienti circa l'uso del medicinale in donne g ravide. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eGli studi nell'animale non sono sufficienti riguardo agli effe tti in gravidanza, allo sviluppo embrio\/fetale, al parto e allo svilup po postnatale. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIl rischio potenziale nell'uomo e' sconosciuto. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIl farm aco non deve essere usato in gravidanza se non sussiste una chiara nec essita'. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eNon e' noto se l'ipratropio bromuro e la xilometazolina clori drato sono escreti nel latte materno. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eL'esposizione sistemica all'ipra tropio bromuro e alla xilometazolina cloridrato e' bassa. \u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eGli effetti sul neonato allattato al seno sono quindi improbabili.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eIl bisogno del trattamento con il prodotto per la madre ei vantaggi dell'allattame e devono essere soppesati rispetto ai rischi potenziali per il neonato.\u003c\/font\u003e\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: 12pt;\"\u003e\u003cstrong\u003e\u003ca href=\"https:\/\/www.easyfarma.it\/zuccari-olio-del-re-spray-nasale-decongestionante-formato-maxi\" target=\"_blank\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003e\u003cfont style=\"vertical-align: inherit;\"\u003eSCOPRI L'ALTERNATIVA NATURALE A Rinazina SENZA EFFETTI COLLATERALI\u003c\/font\u003e\u003c\/font\u003e\u003c\/a\u003e\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"SalusMarket Salute e Benessere Online","offers":[{"title":"Default Title","offer_id":53459785089366,"sku":"39064011","price":11.81,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0968\/4507\/0678\/files\/Rinaziona-spray_nasali-039064011-1.webp?v=1778217091","url":"https:\/\/farmasmart.shop\/products\/rinazina-doppia-azione-0-5-mg-ml-0-6-mg-ml-spary-nasale-10-ml-acquista-online-su-farmaclick","provider":"SalusMarket Salute e Benessere Online","version":"1.0","type":"link"}